148 related articles for article (PubMed ID: 3416325)
1. Comparative studies between in vitro and in vivo effects of human beta-interferon on natural killer activity and its relevance to immunochemotherapy.
D'Atri S; Fuggetta MP; Giganti G; Tentori L; Roselli M; Nunziata C; Pastore S; Bonmassar E; De Vecchis L
Cancer Immunol Immunother; 1988; 27(2):163-70. PubMed ID: 3416325
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of recombinant interferon-alpha and 5-fluorouracil against colon cancer cells or against peripheral blood mononuclear cells.
De Filippi R; Prete SP; Giuliani A; Silvi E; Yamaue H; Nieroda CA; Greiner JW; De Vecchis L; Bonmassar E
Anticancer Res; 1994; 14(5A):1767-73. PubMed ID: 7847809
[TBL] [Abstract][Full Text] [Related]
3. Modulation by interferon alpha of the decreased natural killer activity in patients with glioblastoma.
Lapeña P; Isasi C; Vaquero J; Martinez R; Alvarez-Mon M
Acta Neurochir (Wien); 1991; 109(3-4):109-13. PubMed ID: 1858528
[TBL] [Abstract][Full Text] [Related]
4. Role of biological response modifiers in immunochemotherapy of solid tumors and retroviral-induced leukemia.
Fuggetta MP; D'Onofrio C; Bonmassar E
Ann Ist Super Sanita; 1990; 26(3-4):385-95. PubMed ID: 1708953
[TBL] [Abstract][Full Text] [Related]
5. Combination treatment of 2-chlorodeoxyadenosine and type I interferon on hairy cell leukemia-like cells: cytotoxic effect and MHC-unrestricted killer cell regulation.
Reiter Z; Tomson S; Ozes ON; Taylor MW
Blood; 1993 Apr; 81(7):1699-708. PubMed ID: 8096405
[TBL] [Abstract][Full Text] [Related]
6. A dual anti-tumor effect of a combination of interferon-alpha or interleukin-2 and 5-fluorouracil on natural killer (NK) cell-mediated cytotoxicity.
Reiter Z; Ozes ON; Blatt LM; Taylor MW
Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):103-11. PubMed ID: 1370257
[TBL] [Abstract][Full Text] [Related]
7. Synergism between alpha-interferon and interleukin-2-activated killer cells: in vitro studies.
Di Raimondo F; LaPushin R; Hersh EM
Acta Haematol; 1987; 78 Suppl 1():77-83. PubMed ID: 3124452
[TBL] [Abstract][Full Text] [Related]
8. Effect of hydrocortisone on human natural killer activity and its modulation by beta interferon.
Fuggetta MP; Graziani G; Aquino A; D'Atri S; Bonmassar E
Int J Immunopharmacol; 1988; 10(6):687-94. PubMed ID: 3198305
[TBL] [Abstract][Full Text] [Related]
9. Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapy.
Tentori L; Fuggetta MP; D'Atri S; Aquino A; Nunziata C; Roselli M; Ballatore P; Bonmassar E; De Vecchis L
Cancer Immunol Immunother; 1987; 24(1):86-91. PubMed ID: 3815421
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the defective natural killer activity seen in thalassaemia major with desferrioxamine and alpha-interferon.
Akbar AN; Fitzgerald-Bocarsly PA; Giardina PJ; Hilgartner MW; Grady RW
Clin Exp Immunol; 1987 Nov; 70(2):345-53. PubMed ID: 3427826
[TBL] [Abstract][Full Text] [Related]
11. Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon.
Lotzová E; Savary CA; Quesada JR; Gutterman JU; Hersh EM
J Natl Cancer Inst; 1983 Nov; 71(5):903-10. PubMed ID: 6580490
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of human natural killer cell function by the combined effects of tumor necrosis factor alpha or interleukin-1 and interferon-alpha or interleukin-2.
Ostensen ME; Thiele DL; Lipsky PE
J Biol Response Mod; 1989 Feb; 8(1):53-61. PubMed ID: 2493514
[TBL] [Abstract][Full Text] [Related]
13. A possible role for interferon-alpha and activated natural killer cells in remission of AIDS-related Kaposi's sarcoma: in vitro studies.
Reiter Z; Ozés ON; Blatt LM; Sturzl M; Taylor MW
J Acquir Immune Defic Syndr (1988); 1992; 5(5):469-76. PubMed ID: 1560343
[TBL] [Abstract][Full Text] [Related]
14. In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells.
Uchida A; Yanagawa E; Kokoschka EM; Micksche M; Koren HS
Br J Cancer; 1984 Oct; 50(4):483-92. PubMed ID: 6237664
[TBL] [Abstract][Full Text] [Related]
15. Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells.
Lee SM; Suen Y; Chang L; Bruner V; Qian J; Indes J; Knoppel E; van de Ven C; Cairo MS
Blood; 1996 Aug; 88(3):945-54. PubMed ID: 8704253
[TBL] [Abstract][Full Text] [Related]
16. The effect of recombinant alpha 2-interferon on defective natural killer cell activity in multiple sclerosis.
Hirsch RL; Johnson KP
Neurology; 1985 Apr; 35(4):597-600. PubMed ID: 3982654
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell activity against cultured melanoma cells: a dye-reduction technique with studies on augmented activity by interferon subtypes.
Losinno C; Wines BD; Johns TG; Mackay IR
Nat Immun; 1992; 11(4):215-24. PubMed ID: 1384830
[TBL] [Abstract][Full Text] [Related]
18. cis-Diamminedichloroplatinum and 5-fluorouracil are potent inducers of the cytokines and natural killer cell activity in vivo and in vitro.
Okamoto M; Kasetani H; Kaji R; Goda H; Ohe G; Yoshida H; Sato M
Cancer Immunol Immunother; 1998 Dec; 47(4):233-41. PubMed ID: 9875677
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells in children with malignant solid tumors. Effect of recombinant interferon-alpha and interleukin-2 on natural killer cell function against tumor cell lines.
Alvarado CS; Findley HW; Chan WC; Hnath RS; Abdel-Mageed A; Pais RC; Kutner MH; Ragab AH
Cancer; 1989 Jan; 63(1):83-9. PubMed ID: 2783377
[TBL] [Abstract][Full Text] [Related]
20. Immuno-chemotherapy of advanced colorectal cancer with alpha-2a interferon and 5-fluorouracil. Immunopharmacological studies.
De Filippi R; Cucchiara G; Prete SP; Marini S; Ricci F; Nunziata C; Turriziani M; Bonmassar E; Fuggetta MP; De Vecchis L
Ann Oncol; 1991; 2(10):759-64. PubMed ID: 1801883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
